tiprankstipranks
Trending News
More News >
Harmony Biosciences Holdings (HRMY)
NASDAQ:HRMY
US Market

Harmony Biosciences Holdings (HRMY) Income Statement

Compare
409 Followers

Harmony Biosciences Holdings Income Statement

Last quarter (Q3 2025), Harmony Biosciences Holdings's total revenue was $239.46M, an increase of 28.71% from the same quarter last year. In Q3, Harmony Biosciences Holdings's net income was $50.87M. See Harmony Biosciences Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 714.73M$ 582.02M$ 437.86M$ 305.44M$ 159.74M
Gross Profit
$ 557.92M$ 460.79M$ 354.37M$ 249.92M$ 132.00M
Operating Expenses
$ 367.09M$ 268.76M$ 234.19M$ 162.39M$ 115.02M
Depreciation and Amortization
$ 24.11M$ 24.36M$ 23.39M$ 18.84M$ 10.24M
EBITDA
$ 233.41M$ 221.51M$ 146.87M$ 80.46M$ 1.51M
Operating Income
$ 190.83M$ 192.03M$ 120.19M$ 87.53M$ 16.99M
Other Income/Expenses
$ 978.00K$ -18.63M$ -15.50M$ -50.10M$ -53.93M
Pretax Income
$ 191.80M$ 173.40M$ 104.69M$ 37.43M$ -36.94M
Net Income
$ 145.49M$ 128.85M$ 181.47M$ 34.60M$ -36.94M
Per Share Metrics
Basic EPS
$ 2.56$ 2.17$ 3.07$ 0.60$ -1.12
Diluted EPS
$ 2.51$ 2.13$ 2.97$ 0.58$ -1.10
Weighted Average Shares Outstanding
56.88M 59.47M 59.17M 57.53M 56.89M
Weighted Average Shares Outstanding (Diluted)
57.87M 60.37M 61.10M 59.21M 57.85M
Currency in USD

Harmony Biosciences Holdings Earnings and Revenue History